Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Assets (2016 - 2025)

Historic Current Assets for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to $28.0 million.

  • Sunshine Biopharma's Current Assets rose 764.14% to $28.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year increase of 764.14%. This contributed to the annual value of $26.0 million for FY2024, which is 432.42% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Current Assets of $28.0 million as of Q3 2025, which was up 764.14% from $27.9 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Current Assets ranged from a high of $42.0 million in Q2 2022 and a low of $1.8 million during Q2 2021
  • For the 5-year period, Sunshine Biopharma's Current Assets averaged around $22.1 million, with its median value being $25.7 million (2024).
  • Its Current Assets has fluctuated over the past 5 years, first surged by 531351.14% in 2021, then crashed by 3784.44% in 2023.
  • Sunshine Biopharma's Current Assets (Quarter) stood at $2.2 million in 2021, then skyrocketed by 1143.83% to $27.3 million in 2022, then fell by 8.87% to $24.9 million in 2023, then rose by 4.32% to $26.0 million in 2024, then increased by 7.71% to $28.0 million in 2025.
  • Its Current Assets was $28.0 million in Q3 2025, compared to $27.9 million in Q2 2025 and $24.5 million in Q1 2025.